2013 American Transplant Congress
Inflammatory Bowel Disease in Renal Transplant Recipients: A Retrospective Multicenter Study
Inflammatory bowel disease (IBD) can occur before or, despite corticoids and immunosuppressive treatment, after transplantation. We collected characteristics of cases of IBD in renal transplant…2013 American Transplant Congress
Neurokinin-1 Receptor-Signaling of T Cells and Dendritic Cells Is Required for Optimal Elicitation of the T-Cell Response That Leads to Graft Rejection
Increasing evidence suggests that elicitation of donor–reactive T-cell immunity is regulated by pro-inflammatory neuropeptides. Substance P (SP) is the prototypic pro-inflammatory neuropeptide released by leukocytes…2013 American Transplant Congress
Does Length of Hospital Stay and Hospital-Wide Incidence Have an Impact on Clostridium Difficile Infection (CDI) in Organ Transplant Recipients?
University of North Carolina, Chapel Hill
Several risk factors contributing to CDI have been identified in organ transplant recipients (Txs)(Transplantation 2012; 93:1051-57). Among these factors is hospital length of stay (LOS).…2013 American Transplant Congress
Multi-Center, International Registry of Cardiac Transplantation for Light Chain (AL) and Transthyreitin (TTR) Amyloidosis, A
BackgroundAL and TTR cardiac amyloid has a median survival of only 6-8 months, untreated. Orthotopic heart transplant (OHT) followed by stem cell transplant (SCT) for…2013 American Transplant Congress
Extended-Release Tacrolimus Therapy Is Effective and Safe in De Novo Kidney Transplant Recipients from Living and Expanded, Standard, or after Cardiac Death Deceased Donors
Nephrology, Hospital 12 de Octubre, Madrid, Spain
Nonadherence is one of the most important causes of late renal graft loss. A single daily dose of tacrolimus in the morning beginning immediately after…2013 American Transplant Congress
Serum and Urine IP–10 and Fractalkine Are Effective Biomarkers for Prediction of Early Kidney Transplant Rejection
Background: Chemotactic factors play an important role in acute rejection. The aims of our study were to examine the expression of serum and urine IP-10…2013 American Transplant Congress
Liver Transplant (OLT) Length of Stay (LOS) 2000-2010: An Analysis of the UNOS/OPTN Database
General Surgery, Cleveland Clinic, Cleveland, OH
Aim: To define regional patterns in post OLT LOS.Methods: Using the UNOS database (06/2011) we reviewed data on 65,891 OLT recipients, 01/2000-12/2010. Patients excluded (n=11,784)…2013 American Transplant Congress
Kidney Transplant Outcomes by Living Donor (LD) Relationship
From 2007 to 2011, the proportion of LDs from paired kidney donor (PKD) programs tripled (3.5%-10.8%) and from non-directed donors (NDD) doubled (1.3%-2.6%). As these…2013 American Transplant Congress
Status 1A Utilization for Heart Transplant Candidates with Ventricular Assist Devices (VADs)
Background: OPTN policy 3.7.3(a)(i) allows heart transplant candidates with ventricular assist devices (VAD) to be listed as Status 1A for 30 days at any time…2013 American Transplant Congress
Surgical Complication Rates in Patients Receiving Kidney Transplants in England: Analysis by Transplant Centre Using Linked Registry and Hospitalisation Data
Introduction: Previous UK studies have found similar centre-specific graft and patient survival following first transplantation, however other measures of surgical performance have not previously been…
- « Previous Page
- 1
- …
- 143
- 144
- 145
- 146
- 147
- …
- 178
- Next Page »